BWM
FLGT icon

BerganKDV Wealth Management’s Fulgent Genetics FLGT Stock Holding History

BerganKDV Wealth Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$186 Buy
+5
New +$174 ﹤0.01% 846

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

BerganKDV Wealth Management's FLGT Position: Q2 2023 in Review

BerganKDV Wealth Management opened a new position in Fulgent Genetics (FLGT) in Q2 2023: 5 shares worth $186. The stake represents ﹤0.01% of the portfolio and ranks #846 among its holdings.

214 funds tracked by Wall St. Rank hold FLGT as of Q2 2023.

  • BerganKDV Wealth Management held 5 shares of Fulgent Genetics worth $186 as of Q2 2023.
  • Fulgent Genetics was a new BerganKDV Wealth Management position in Q2 2023.
  • Fulgent Genetics made up ﹤0.01% of BerganKDV Wealth Management's portfolio in Q2 2023, its #846 holding.
  • 214 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2023.

Based on BerganKDV Wealth Management's 13F filing for Q2 2023, filed 24 Jul 2023.